logo
Veterinary Nonprofit Helps Pets And People After Myanmar Earthquake

Veterinary Nonprofit Helps Pets And People After Myanmar Earthquake

Forbes25-04-2025

When a 7.7 magnitude earthquake struck Myanmar on March 28, the epicenter was near the country's second-largest city, Mandalay. The tremor collapsed buildings and killed an estimated 10,000 people. Roads and bridges buckled as the city lost power and water, with many newly homeless residents or people living in unstable buildings forced to live on the streets without access to sanitation as aftershocks continued to rock the region.
Somehow, the entire team and the Mandalay office of the nonprofit Lets Save the Strays International survived — to the immense relief of Massachusetts veterinarian Amy Shroff, VMD, the group's founder and president.
'Our team is safe. Their families are safe. The feeders are safe. Most of the animals are safe,' she says. 'It's amazing that they're safe.'
Despite some losing their homes and one veterinary clinic, the team is working overtime to help pets and people impacted by the earthquake and aftershocks.
Normally, Lets Save the Strays focuses on TVNR — aka Trap, Vaccinate, Neuter and Release — working to humanely trap stray dogs and cats, vaccinate them against rabies, spay or neuter them, and after a day or two of recovery, return them to their outdoor realm.
They'll set up what's essentially a veterinary MASH unit at schools, stadiums, police stations, hospitals, monasteries, universities and senior centers in response to requests for help. The team consists of five local veterinarians, several veterinary technicians, a bookkeeper, animal catcher and a 'whole gaggle' of volunteers, with help from around 20 'street feeders' who feed strays out of kindness, Dr. Shroff says.
Since 2016, Lets Save the Strays has performed TVNR on nearly 20,000 dogs in Myanmar — around 600 dogs a month prior to the earthquake. Before that intervention, strays were being poisoned 'by the truckload,' according to Dr. Shroff.
'I thought, 'Why don't we start doing TVNR ourselves and show the government and the community that it can work,' and it's exploded,' she says. 'We started out small, but everybody wants it. People don't want to poison them. And it really is One Health because by keeping animals healthy, we're keeping the community healthy.'
Since the devastating earthquake in Myanmar — which is also in the throes of a civil war — the Burmese team for Lets Save the Strays has shifted focus to offer free veterinary care, give away pet food and bottled water, and vaccinate any animal brought in.
'It's an amazingly difficult yet inspirational situation,' Dr. Shroff says.
She's deeply concerned about the 'major humanitarian crisis' in Myanmar.
'Myanmar is a country of very little resource, so there's not a lot of infrastructure. It's an older country. It's in the middle of a civil war. The government is a military regime, which is constantly bombing and killing people in some of the areas of the country where active fighting is going on, and Mandalay is close to that active fighting,' she says. 'And then you have an earthquake that just topples these older buildings and beautiful monasteries and pagodas — it is just absolutely horrible.'
So Lets Save the Strays is prioritizing helping pets to help the local people. Since March 30, the nonprofit has given away thousands of pounds of food for dogs and cats, and is providing veterinary care to 12-30 pets every day.
Earlier this week, the team traveled to an impoverished village near Mandalay where nearly 400 homes were lost in the earthquake to feed, vaccinate, deworm and treat pets for mange and other health issues, according to Dr. Shroff.
'People are having trouble feeding themselves and taking care of themselves so we can help them with their pets, which is sometimes the only thing that they have,' she says.
An emergency grant from the International Fund for Animal Welfare and donations of food from pet stores have helped fuel efforts, but she says financial donations are still desperately needed, and that even $5 goes a long way in Myanmar.
'I want people to know this crisis is still ongoing and it's not going away anytime soon,' she says. 'We need all hands on deck.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps

Yahoo

time5 days ago

  • Yahoo

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps

Sagimet Biosciences Inc. (NASDAQ:SGMT) said on Wednesday that denifanstat met all primary and secondary endpoints in a Phase 3 trial for moderate to severe acne vulgaris. The trial was conducted by Sagimet's license partner, Ascletis Bioscience Co. Ltd., in China. Denifanstat is a once-daily oral small-molecule fatty acid synthase (FASN) inhibitor being developed by Ascletis as ASC40 for acne in China and by Sagimet for metabolic dysfunction-associated steatohepatitis (MASH) in the rest of the Sagimet recently initiated a Phase 1 first-in-human trial with a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the U.S. The trial randomized 480 patients in China to receive either denifanstat once daily or a placebo for 12 weeks. For the primary endpoint of treatment success, defined as an Investigator's Global Assessment score of 0 (clear) or 1 (almost clear) with at least a 2-point decrease from baseline at week 12, the denifanstat group demonstrated a statistically significant 33.2% rate over the placebo group's 14.6%. Additional goals further corroborated denifanstat's efficacy versus placebo, including: Reduction in total lesion count (57.4% vs 35.4%). Reduction in inflammatory lesion count (63.5% vs 43.2%). Reduction in non-inflammatory lesion count (51.9% vs. 28.9%). Ascletis reported that denifanstat was generally well-tolerated. Following 12 weeks of once-daily oral administration at 50 mg, treatment-emergent adverse events (TEAE) incidence rates were comparable between denifanstat and placebo. All denifanstat-related adverse events (AEs) were mild or moderate. There were no denifanstat-related grade 3 or 4 AEs and no denifanstat-related serious AEs. No deaths were reported. These Phase 3 results confirm that FASN inhibition represents a potential therapeutic approach within acne. Ascletis has indicated that it plans to submit denifanstat for approval to the China National Medical Products Administration. Building on Ascletis' Phase 3 results, Sagimet has recently initiated a Phase 1 first-in-human clinical trial with a second oral FASN inhibitor drug candidate, TVB-3567, that is planned to be developed for acne in the U.S. In other notable pharmaceutical industry news, GSK plc (NYSE:GSK) agreed to acquire Boston Pharmaceuticals' lead asset, efimosfermin alfa, a phase 3-ready, investigational specialty medicine for treating and preventing the progression of steatotic liver disease in May. Under the agreement, GSK will pay up to $2 billion in total cash consideration, including $1.2 billion upfront, with the potential for additional success-based milestone payments totaling $800 million. This highlights ongoing investment in the liver disease space, an area where Sagimet is also active with its MASH program. Price Action: SGMT stock is trading higher by 31.7% to $4.78 premarket at last check Wednesday. Read Next:Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Alan Alda, Mike Farrell Among Those Paying Tribute to Loretta Swit: 'A Supremely Talented Actor'
Alan Alda, Mike Farrell Among Those Paying Tribute to Loretta Swit: 'A Supremely Talented Actor'

Yahoo

time31-05-2025

  • Yahoo

Alan Alda, Mike Farrell Among Those Paying Tribute to Loretta Swit: 'A Supremely Talented Actor'

Hollywood is paying tribute to Loretta Swit after news of her death was announced Friday. According to a police report, the M*A*S*H star died of suspected natural causes at her home in New York City, her publicist, Harlan Boll, announced. More from The Hollywood Reporter Valerie Mahaffey, Actress on 'Northern Exposure,' 'Desperate Housewives' and 'Young Sheldon,' Dies at 71 Alf Clausen, Emmy-Winning Composer for 'The Simpsons,' Dies at 84 Loretta Swit, Margaret "Hot Lips" Houlihan on 'M*A*S*H,' Dies at 87 Swit appeared in all but 11 episodes of M*A*S*H during its 11-season run, earning two Emmys for her portrayal of Maj. Margaret 'Hot Lips' Houlihan. Notably, she was nominated for 10 Emmys, one for every season she appeared in except season one. After her tenure in the medical war drama, she went on to star in several films, including Freebie and the Bean (1974), Race With the Devil (1975), S.O.B. (1981) and BoardHeads (1998). Alan Alda, Swit's longtime M*A*S*H co-star, paid tribute to her on X. 'Loretta was a supremely talented actor. She deserved all her 10 EMMY nominations and her 2 wins. But more than acting her part, she created it,' he wrote on Friday. 'She worked hard in showing the writing staff how they could turn the character from a one joke sexist stereotype into a real person — with real feelings and ambitions. We celebrated the day the script came out, listing her character not as Hot Lips but as Margaret. Loretta made the most of her time here.' Mike Farrell, who joined the series in season four, shared a photo of the late actress on Instagram, writing, 'Loretta… 1937-2025.' In a statement to The Hollywood Reporter, Journey Gunderson, the executive director of the National Comedy Center, said, 'Loretta Swit's portrayal of Margaret 'Hot Lips' Houlihan was groundbreaking – bringing heart, humor, and strength to one of television comedy's most enduring roles. Her talent extended well beyond that iconic character, with acclaimed work on both stage and screen that showcased her intelligence, versatility, and passion. That legacy endures through the cultural impact of MASH, which is proudly represented in the National Comedy Center.' Best of The Hollywood Reporter 'The Studio': 30 Famous Faces Who Play (a Version of) Themselves in the Hollywood-Based Series 22 of the Most Shocking Character Deaths in Television History A 'Star Wars' Timeline: All the Movies and TV Shows in the Franchise

Loretta Swit, M*A*S*H Star, Dies at 87
Loretta Swit, M*A*S*H Star, Dies at 87

Yahoo

time31-05-2025

  • Yahoo

Loretta Swit, M*A*S*H Star, Dies at 87

Loretta Swit, beloved for her groundbreaking role as Major Margaret 'Hot Lips' Houlihan on M*A*S*H, died on May 30, 2025. She was 87. Swit's portrayal of Major Houlihan helped transform the character from a punchline to a powerful presence—one of the first truly complex female figures in primetime comedy. Over the show's 11-season run, Swit was nominated for an Emmy every season, winning twice, in 1980 and 1982. Her passing drew heartfelt tributes from fans and longtime co-stars Alan Alda, Mike Farrell, and Jamie Farr, as well as from PETA, where she was a passionate advocate for animal rights. Jamie Farr said in a statement released to USA Today: 'I dearly loved Loretta! As close as family can get… I can't begin to express how much she will be missed.' According to PETA's website, Swit 'worked with many animal charities and had her own called 'SwitHeart Animal Alliance.' This charity works to bring back dogs from Afghanistan to reunite them with their human companions and matches veterans with homeless animals.' They also ask that those who can would adopt a new friend from a shelter in her memory. Behind the scenes, Swit was a vocal advocate for gender equity, pushing for deeper storylines for women both in the writers' room and onscreen. Standing up to a male-dominated industry can be lonely. In one memorable scene, Major Houlihan finally expresses her loneliness and need for someone on her side, but Swit is clearly speaking from her own heart. ☕️ #ClassicMASH #MASH #mash4077 #war #majormargarethoulihan #margarethoulihan #hotlips #lorettaswit #coffee " class="tiktok-embed" data-video-id="7251202849466535211"> Though set during the Korean War, M*A*S*H spoke to a generation grappling with Vietnam, Watergate, and shifting social norms. The show's mix of humor and heartbreak helped audiences process the real costs of war and still does. It continues to air in reruns, especially around Memorial Day and Veterans Day, reminding viewers that behind every uniform is a human story. Swit's legacy lives on in those stories and in the countless lives she touched, both on and off screen.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store